Interleukin-33 involved in immunity to SARS-CoV-2 https://www.mpg.de/16704444/0408-immu-interleukin-33-involved-in-immunity-to-sars-cov-2-153800-x
Study by Max Planck researchers and physicians from the University of Freiburg Medical Center unveil a novel feature of COVID-19 immunity, which could have implications for future therapies. The study points to the involvement of Interleukin 33, an important danger signal, when immune cells encounter SARS-CoV-2 for a second time.
Corona Social Sciences Shift in deaths from the very old to people in middle age Wind